Trial
NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Autoimmunity Centers of Excellence; Rho Federal Systems Division, Inc.
Condition
Rheumatoid Arthritis (RA)
Intervention
Moderna mRNA-1273
Why stopped
The study was closed due to continued enrollment hurdles.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-10